Sign In
Buy IOVA
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
BrainCool AB (publ) : - market clearance in Europe for Cooral® Systems to prevent Oral Mukosit | MarketScreener
09:30am, Wednesday, 17'th Jun 2020AIIMS conducts pilot study to assess effect of radiation therapy on Covid-19 patients
09:21am, Wednesday, 17'th Jun 2020
The government on Saturday released a revised protocol for the treatment of coronavirus infection, allowing use of antiviral drug remdesivir in moderate cases and hydroxychloroquine in patients during
Was Krebszellen beim Überleben unter Stress hilft
08:16am, Wednesday, 17'th Jun 2020
Molekularer Schutzmechanismus als potentieller Lichtblick für die Krebstherapie.
FerGene Appoints Top Biotech Leaders to Executive Team
12:00am, Wednesday, 17'th Jun 2020
FerGene, Inc., a privately held gene therapy company dedicated to revolutionizing the treatment of bladder cancer, today announced the appointment of
Xconomy: Pharma Partnering: Perspectives from Xcelerating Life Sciences Panel
02:21pm, Tuesday, 16'th Jun 2020
At some point, every biotech weighs whether to forge ahead alone or team up with a larger company that has the scientific know-how, clinical trial
Hat in hand: U.S. scientists scramble to support their COVID immunity research
11:54am, Tuesday, 16'th Jun 2020
It wasn’t easy to build a COVID-19 antibody test during Illinois’ statewide lockdown.
Hat in hand: U.S. scientists scramble to support their COVID immunity research
11:54am, Tuesday, 16'th Jun 2020
It wasn’t easy to build a COVID-19 antibody test during Illinois’ statewide lockdown.
Hat in hand: U.S. scientists scramble to support their COVID immunity research
11:44am, Tuesday, 16'th Jun 2020
It wasn’t easy to build a COVID-19 antibody test during Illinois’ statewide lockdown.
Insight: Hat in hand - U.S. scientists scramble to support their COVID immunity research
11:17am, Tuesday, 16'th Jun 2020
It wasn’t easy to build a COVID-19 antibody test during Illinois’ statewide lockdown.
INSIGHT-Hat in hand: U.S. scientists scramble to support their COVID immunity research
11:02am, Tuesday, 16'th Jun 2020
However, $306 million of the federal money has been set aside for the National Cancer Institute to expand antibody testing capacity and fund research projects, according to a public presentation last
Cancer patients and doctors carry on with clinical trials during Covid-19
08:40am, Tuesday, 16'th Jun 2020
In the early days of the pandemic, patients and doctors were uncertain about how they would proceed with research — but no one ever doubted that they would.
Oppenheimer Issues a Buy Rating on Iovance Biotherapeutics (IOVA) - Markets
03:53am, Tuesday, 16'th Jun 2020
In a report released yesterday, Mark Breidenbach from Oppenheimer assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research Report),
Hat in hand: U.S. scientists scramble to support their COVID immunity research
12:00am, Tuesday, 16'th Jun 2020
Hat in hand: U.S. scientists scramble to support their COVID immunity research
